Acoramidis showed a 42% reduction in all-cause mortality and cardiovascular hospitalizations at 30 months compared to placebo in the ATTRibute-CM trial. Continuous acoramidis use resulted in a 48. ...
(Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced the opening of Ntrust-2 to enrollment and the IND clearance for an ...
The San Francisco 49ers will reveal their passions beyond the game through their customized footwear for the NFL's 2024 My Cause My Cleats campaign in Week 14. On the December 8 game against the ...
Here's what myasthenia gravis is, what causes it, and what treatment options exist if you or someone you love is affected. Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular ...
This causes weakness in those muscles ... At this time, there is no cure for myasthenia gravis. Treatment depends on the scope and severity of each person’s symptoms and how quickly the disease ...